Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Durham

Showing results (411-420 of 477) with videos related to

Pageof 48
Sort By:
Allergy|February 14, 2021
Innate lymphoid cells: The missing part of a puzzle in food allergyUmit M Sahiner, Janice A Layhadi, Korneliusz Golebski, et al.
Neurosurgery|August 17, 2019
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Management of Patients With Myelomeningocele: Whether Persistent Ventriculomegaly Adversely Impacts Neurocognitive DevelopmentJeffrey P Blount, Susan R Durham, Paul Klimo, et al.
Allergy|January 12, 2018
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patientsR Mösges, A F Koch, E Raskopf, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
Neurosurgery|August 17, 2019
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele: Executive SummaryCatherine A Mazzola, Nadege Assassi, Lissa C Baird, et al.
The Journal of Allergy and Clinical Immunology|July 25, 2020
Cardiovascular changes during peanut-induced allergic reactions in human subjectsMonica Ruiz-Garcia, Joan Bartra, Olaya Alvarez, et al.
Allergy|July 14, 2023
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperJasper Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
European Journal of Immunology|July 13, 2002
CCR4 in human allergen-induced late responses in the skin and lungKayhan T Nouri-Aria, Duncan Wilson, James N Francis, et al.
Pageof 48

Showing results (411-420 of 477) with videos related to

Sort By:
Pageof 48
Allergy|February 14, 2021
Innate lymphoid cells: The missing part of a puzzle in food allergyUmit M Sahiner, Janice A Layhadi, Korneliusz Golebski, et al.
Neurosurgery|August 17, 2019
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Management of Patients With Myelomeningocele: Whether Persistent Ventriculomegaly Adversely Impacts Neurocognitive DevelopmentJeffrey P Blount, Susan R Durham, Paul Klimo, et al.
Allergy|January 12, 2018
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patientsR Mösges, A F Koch, E Raskopf, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2017
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trialClaus Bachert, Ana R Sousa, Valerie J Lund, et al.
Neurosurgery|August 17, 2019
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele: Executive SummaryCatherine A Mazzola, Nadege Assassi, Lissa C Baird, et al.
The Journal of Allergy and Clinical Immunology|July 25, 2020
Cardiovascular changes during peanut-induced allergic reactions in human subjectsMonica Ruiz-Garcia, Joan Bartra, Olaya Alvarez, et al.
Allergy|July 14, 2023
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperJasper Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
European Journal of Immunology|July 13, 2002
CCR4 in human allergen-induced late responses in the skin and lungKayhan T Nouri-Aria, Duncan Wilson, James N Francis, et al.
Pageof 48